3-(3-FLUORO-4-(6-(2H-TETRAZOL-5-YL)-3-PYRIDINYL)PHENYL)-5-((PHOSPHONOOXY)METHYL)-2-OXAZOLIDINONE, (5R)-
UNII Y33D7ML97B
Substance Identification & Data
This profile provides standardized clinical and technical data for 3-(3-fluoro-4-(6-(2h-tetrazol-5-yl)-3-pyridinyl)phenyl)-5-((phosphonooxy)methyl)-2-oxazolidinone, (5r)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Y33D7ML97B.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1239662-47-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C16H14FN6O6P HZQMHJRVOKLJLV-LLVKDONJSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 3-(3-fluoro-4-(6-(2h-tetrazol-5-yl)-3-pyridinyl)phenyl)-5-((phosphonooxy)methyl)-2-oxazolidinone, (5r)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.